Back to Trades
Other4
HALOZYME THERAPEUTICS, INC.
HALO
Total Value
$720.4K
Company Information
- Company Name
- HALOZYME THERAPEUTICS, INC.
- Ticker Symbol
- HALO
- CIK
- 0001159036
Insider Information
- Role
- SVP, CHIEF LEGAL OFFICER
- Location
- SAN DIEGO, CA
Officer
Filing Details
- Filing Date
- Feb 17, 2026
- Transaction Date
- Feb 16, 2026
- Accession Number
- 0001159036-26-000027
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 16, 2026 | Common Stock | 4,796 | — | Exercise | — |
| Feb 16, 2026 | Common Stock | 2,587 | $79.44 | Tax Withholding | $205.5K |
| Feb 16, 2026 | Common Stock | 12,016 | — | Exercise | — |
| Feb 16, 2026 | Common Stock | 6,481 | $79.44 | Tax Withholding | $514.9K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 16, 2026 | Derivative | 4,796 | — | Exercise | — |
| Feb 16, 2026 | Derivative | 12,016 | — | Exercise | — |
Footnotes
- (F1)The reported disposition of 2,587 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F2)The reported disposition of 6,481 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- (F3)This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
- (F4)This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.